Rchr

J-GLOBAL ID：201401059428138050 Update date: Jun. 09, 2020

Takahashi Masanobu

タカハシマサノブ | Takahashi Masanobu

Affiliation and department：
Job title： Lecturer
Homepage URL (2)： http://db.tohoku.ac.jp/whois/detail/f5ad94efa66ba9b003db1e2474bcda8d.html , http://db.tohoku.ac.jp/whois/e_detail/f5ad94efa66ba9b003db1e2474bcda8d.html

Research keywords (1)： Clinical Oncology

Papers (18)：

Keun Hur, Yuji Toiyama, Masanobu Takahashi, Francesc Balaguer, Takeshi Nagasaka, Junichi Koike, Hiromichi Hemmi, Minoru Koi, C. Richard Boland, Ajay Goel. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. GUT. 2013. 62. 9. 1315-1326
Yuji Toiyama, Masanobu Takahashi, Keun Hur, Takeshi Nagasaka, Koji Tanaka, Yasuhiro Inoue, Masato Kusunoki, C. Richard Boland, Ajay Goel. Serum miR-21 as a Diagnostic and Prognostic Biomarker in Colorectal Cancer. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2013. 105. 12. 849-859
Masanobu Takahashi, Bokyung Sung, Yan Shen, Keun Hur, Alexander Link, C. Richard Boland, Bharat B. Aggarwal, Ajay Goel. Boswellic acid exerts antitumor effects in colorectal cancer cells by modulating expression of the let-7 and miR-200 microRNA family. CARCINOGENESIS. 2012. 33. 12. 2441-2449
Masanobu Takahashi, Yoichi Furukawa, Hideki Shimodaira, Masato Sakayori, Takuya Moriya, Yoshihiro Moriya, Yusuke Nakamura, Chikashi Ishioka. Aberrant splicing caused by a MLH1 splice donor site mutation found in a young Japanese patient with Lynch syndrome. FAMILIAL CANCER. 2012. 11. 4. 559-564
Masanobu Takahashi, Miriam Cuatrecasas, Francesc Balaguer, Keun Hur, Yuji Toiyama, Antoni Castells, C. Richard Boland, Ajay Goel. The Clinical Significance of MiR-148a as a Predictive Biomarker in Patients with Advanced Colorectal Cancer. PLOS ONE. 2012. 7. 10. e46684

ｍore...

MISC (1)：

下平秀樹, 高橋雅信, 石岡千加史. 【わが国のHNPCC研究基礎と臨床】遺伝性非ポリポーシス大腸癌(HNPCC)の原因となる機能欠損検出 (家族性腫瘍). 家族性腫瘍. 2007. 7. 1. 8-10

Lectures and oral presentations (9)：

CVD療法を施行し病勢進行を抑制することができた悪性褐色細胞腫の2例
(第6回日本臨床腫瘍学会 2008)
当科におけるBevacizumab+FOLFOX4療法施行の症例の検討
(第6回日本臨床腫瘍学会 2008)
切除不能再発胆道癌・胆管細胞癌に対してGemcitabineを使用した15例の検討
(第6回日本臨床腫瘍学会 2008)
5FU系単独療法から多剤併用療法へとシフトアップした進行・再発大腸癌症例の検討
(第6回日本臨床腫瘍学会 2008)
当科におけるBevacizumab+FOLFOX4療法施行症例の検討
(第41回制癌剤適応研究会 2008)

ｍore...

Education (2)：

- 2006 Tohoku University
- 1999 Tohoku University

Professional career (1)：

博士(医学) (Tohoku University)

Association Membership(s) (4)：

日本臨床腫瘍学会(2004/01-) , 日本癌治療学会(2002/04-) , 日本癌学会(2002/04-) , 日本内科学会(1999/04-)

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP